{"id":92064,"date":"2023-02-13T15:04:55","date_gmt":"2023-02-13T14:04:55","guid":{"rendered":"https:\/\/www.echosens.com\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/"},"modified":"2023-02-13T15:15:41","modified_gmt":"2023-02-13T14:15:41","slug":"new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash","status":"publish","type":"post","link":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/","title":{"rendered":"New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":37305,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_searchwp_excluded":"","footnotes":""},"categories":[57],"tags":[],"class_list":["post-92064","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release-en-us","topic-clinical-en-us"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH - Echosens<\/title>\n<meta name=\"description\" content=\"The new Practice Guidance from the AASLD suggests the use of VCTE\u2122, a patented technology used by FibroScan\u00ae solutions from Echosens.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH - Echosens\" \/>\n<meta property=\"og:description\" content=\"The new Practice Guidance from the AASLD suggests the use of VCTE\u2122, a patented technology used by FibroScan\u00ae solutions from Echosens.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/\" \/>\n<meta property=\"og:site_name\" content=\"Echosens\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fibroscan.echosens\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-13T14:04:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-13T14:15:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.echosens.com\/wp-content\/uploads\/2021\/10\/fibroscan-630-expert_liver-examination-min.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1779\" \/>\n\t<meta property=\"og:image:height\" content=\"1184\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alice Alzon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Echosens\" \/>\n<meta name=\"twitter:site\" content=\"@Echosens\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alice Alzon\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/\"},\"author\":{\"name\":\"Alice Alzon\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/#\\\/schema\\\/person\\\/cd9e21f092270794d3ea967f98f2a227\"},\"headline\":\"New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH\",\"datePublished\":\"2023-02-13T14:04:55+00:00\",\"dateModified\":\"2023-02-13T14:15:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/\"},\"wordCount\":19,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/fibroscan-630-expert_liver-examination-min.jpg\",\"articleSection\":[\"Press Release\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/\",\"url\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/\",\"name\":\"New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH - Echosens\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/fibroscan-630-expert_liver-examination-min.jpg\",\"datePublished\":\"2023-02-13T14:04:55+00:00\",\"dateModified\":\"2023-02-13T14:15:41+00:00\",\"description\":\"The new Practice Guidance from the AASLD suggests the use of VCTE\u2122, a patented technology used by FibroScan\u00ae solutions from Echosens.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/fibroscan-630-expert_liver-examination-min.jpg\",\"contentUrl\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/fibroscan-630-expert_liver-examination-min.jpg\",\"width\":1779,\"height\":1184},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/#website\",\"url\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/\",\"name\":\"Echosens\",\"description\":\"Un site utilisant WordPress\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/#organization\",\"name\":\"ECHOSENS\",\"url\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.echosens.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ECHOSENS\"},\"image\":{\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/fibroscan.echosens\",\"https:\\\/\\\/x.com\\\/Echosens\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/echosens\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC1myqoq18t1dKPTz0u1eEgg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.echosens.com\\\/en-us\\\/#\\\/schema\\\/person\\\/cd9e21f092270794d3ea967f98f2a227\",\"name\":\"Alice Alzon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g\",\"caption\":\"Alice Alzon\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH - Echosens","description":"The new Practice Guidance from the AASLD suggests the use of VCTE\u2122, a patented technology used by FibroScan\u00ae solutions from Echosens.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/","og_locale":"en_US","og_type":"article","og_title":"New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH - Echosens","og_description":"The new Practice Guidance from the AASLD suggests the use of VCTE\u2122, a patented technology used by FibroScan\u00ae solutions from Echosens.","og_url":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/","og_site_name":"Echosens","article_publisher":"https:\/\/www.facebook.com\/fibroscan.echosens","article_published_time":"2023-02-13T14:04:55+00:00","article_modified_time":"2023-02-13T14:15:41+00:00","og_image":[{"width":1779,"height":1184,"url":"https:\/\/www.echosens.com\/wp-content\/uploads\/2021\/10\/fibroscan-630-expert_liver-examination-min.jpg","type":"image\/jpeg"}],"author":"Alice Alzon","twitter_card":"summary_large_image","twitter_creator":"@Echosens","twitter_site":"@Echosens","twitter_misc":{"Written by":"Alice Alzon"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/#article","isPartOf":{"@id":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/"},"author":{"name":"Alice Alzon","@id":"https:\/\/www.echosens.com\/en-us\/#\/schema\/person\/cd9e21f092270794d3ea967f98f2a227"},"headline":"New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH","datePublished":"2023-02-13T14:04:55+00:00","dateModified":"2023-02-13T14:15:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/"},"wordCount":19,"commentCount":0,"publisher":{"@id":"https:\/\/www.echosens.com\/en-us\/#organization"},"image":{"@id":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/#primaryimage"},"thumbnailUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2021\/10\/fibroscan-630-expert_liver-examination-min.jpg","articleSection":["Press Release"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/","url":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/","name":"New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH - Echosens","isPartOf":{"@id":"https:\/\/www.echosens.com\/en-us\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/#primaryimage"},"image":{"@id":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/#primaryimage"},"thumbnailUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2021\/10\/fibroscan-630-expert_liver-examination-min.jpg","datePublished":"2023-02-13T14:04:55+00:00","dateModified":"2023-02-13T14:15:41+00:00","description":"The new Practice Guidance from the AASLD suggests the use of VCTE\u2122, a patented technology used by FibroScan\u00ae solutions from Echosens.","breadcrumb":{"@id":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/#primaryimage","url":"https:\/\/www.echosens.com\/wp-content\/uploads\/2021\/10\/fibroscan-630-expert_liver-examination-min.jpg","contentUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2021\/10\/fibroscan-630-expert_liver-examination-min.jpg","width":1779,"height":1184},{"@type":"BreadcrumbList","@id":"https:\/\/www.echosens.com\/en-us\/new-aasld-practice-guidance-calls-for-the-use-of-noninvasive-liver-evaluations-for-earlier-detection-of-nafld-and-nash\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.echosens.com\/en-us\/"},{"@type":"ListItem","position":2,"name":"New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH"}]},{"@type":"WebSite","@id":"https:\/\/www.echosens.com\/en-us\/#website","url":"https:\/\/www.echosens.com\/en-us\/","name":"Echosens","description":"Un site utilisant WordPress","publisher":{"@id":"https:\/\/www.echosens.com\/en-us\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.echosens.com\/en-us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.echosens.com\/en-us\/#organization","name":"ECHOSENS","url":"https:\/\/www.echosens.com\/en-us\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.echosens.com\/en-us\/#\/schema\/logo\/image\/","url":"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg","contentUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg","width":1,"height":1,"caption":"ECHOSENS"},"image":{"@id":"https:\/\/www.echosens.com\/en-us\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/fibroscan.echosens","https:\/\/x.com\/Echosens","https:\/\/www.linkedin.com\/company\/echosens\/","https:\/\/www.youtube.com\/channel\/UC1myqoq18t1dKPTz0u1eEgg"]},{"@type":"Person","@id":"https:\/\/www.echosens.com\/en-us\/#\/schema\/person\/cd9e21f092270794d3ea967f98f2a227","name":"Alice Alzon","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g","caption":"Alice Alzon"}}]}},"_links":{"self":[{"href":"https:\/\/www.echosens.com\/en-us\/wp-json\/wp\/v2\/posts\/92064","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.echosens.com\/en-us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.echosens.com\/en-us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/en-us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/en-us\/wp-json\/wp\/v2\/comments?post=92064"}],"version-history":[{"count":1,"href":"https:\/\/www.echosens.com\/en-us\/wp-json\/wp\/v2\/posts\/92064\/revisions"}],"predecessor-version":[{"id":92065,"href":"https:\/\/www.echosens.com\/en-us\/wp-json\/wp\/v2\/posts\/92064\/revisions\/92065"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/en-us\/wp-json\/wp\/v2\/media\/37305"}],"wp:attachment":[{"href":"https:\/\/www.echosens.com\/en-us\/wp-json\/wp\/v2\/media?parent=92064"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.echosens.com\/en-us\/wp-json\/wp\/v2\/categories?post=92064"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.echosens.com\/en-us\/wp-json\/wp\/v2\/tags?post=92064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}